Advanced Medical Solutions Group (LON:AMS) Stock Passes Above 200 Day Moving Average – Here’s Why

Advanced Medical Solutions Group plc (LON:AMS) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 210.91 and traded as high as GBX 212. Advanced Medical Solutions Group shares last traded at GBX 208.50, with a volume of 721,488 shares changing hands.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Berenberg Bank reiterated a “buy” rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 246 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of GBX 273.67.

Advanced Medical Solutions Group Stock Performance

The business has a fifty day simple moving average of GBX 216.74 and a two-hundred day simple moving average of GBX 210.91. The company has a market cap of £450.97 million, a PE ratio of 50.00, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS) last released its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. Research analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.

Insider Transactions at Advanced Medical Solutions Group

In other Advanced Medical Solutions Group news, insider Eddie Johnson sold 18,726 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of GBX 220, for a total transaction of £41,197.20. Also, insider A Christopher (Chris) Meredith sold 50,510 shares of the firm’s stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of GBX 218, for a total transaction of £110,111.80. Insiders own 4.12% of the company’s stock.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.